Zdrowie i gospodarka · 06/09/2018

FDA Releases Draft Guidance on Uncertainty in Medical Device Benefit-Risk Determinations

The US Food and Drug Administration (FDA) has published a draft guidance document outlining its approach to considering uncertainty in medical device premarket decisions, aiming to increase predictability and efficiency in the approval process.